baber/WOPTO huggingface dataset:
Patent CA-2400297-C (CA)
Inventor: MOATS PAUL H
IPC: B29C49/64
Filed: 2001-02-06
Granted: 2005-06-14
Abstract: A heater assembly (20) for heating blow molding plastic preforms (14) includes a plurality of elongated heaters (26) mounted by a housing (24) and extending along a path of conveyance of the preforms in a parallel relationship to each other, and each heater includes an elongated parabolic reflector (44) that reflects radiation from an adjacent elongated bulb (36) to irradiate the conveyed preforms. The heater assembly (20) also includes a quartz window (58) located between the elongated heaters (26) and the conveyed preforms (14) to transmit infrared radiation while blocking longer wavelength radiation so as to provide uniform heating of the conveyed preforms.
Patent CA-2404052-C (CA)
Inventor: NISHI TORU
IPC: F01M11/06
Filed: 2002-09-18
Granted: 2006-01-10
Abstract: A dry-sump lubrication unit for an internal combustion engine for a vehicle. A crankshaft of the vehicle is disposed so as to be parallel with the direction of travel of the vehicle, and in a position offset from a center of the vehicle when viewed from the front or back of the vehicle. A transmission shaft is disposed on the other side thereof. An oil tank is disposed in a crankcase located substantially at the lower center of the crankcase when viewed from the front or back of the vehicle on the rear side with respect to the traveling direction, and/or in a space between the crankcase and a tear case cover. Oil pumps are disposed forwardly of the oil tank. An oil injection pipe extends from the oil tank toward the side surface thereof on the transmission side. The resulting configuration prevents variations in liquid surface of lubricating oil of the vehicle internal combustion engine due to shaking of the vehicle body, and makes it possible to downsize the entire power unit.
Patent CA-2407715-C (CA)
Title: Diagnostics and therapeutics for macular degeneration-related disorders
Inventor: MULLINS ROBERT F
IPC: C12Q1/6883
Filed: 2001-04-30
Granted: 2009-03-24
Abstract: The invention relates to methods for treating, preventing and diagnosing macular degeneration-related disorders.
Patent CA-2408032-C (CA)
Inventor: KILIAAN AMANDA JOHANNE
IPC: A23L33/15
Filed: 2001-05-08
Granted: 2012-08-21
Abstract: La présente invention concerne une préparation convenant à la prévention et/ou au traitement de troubles vasculaires et comprenant les fractions suivantes : fraction a) acides gras polyinsaturés à longue chaîne, fraction b) phospholipides, laquelle fraction contient au moins deux phospholipides différents sélectionnés dans le groupe constitué de phosphatidylsérine, phosphatidylinositole, phosphatidylcholine et phosphatidyléthanolamine, fraction c) composés représentant un facteur dans le métabolisme de la méthionine, laquelle fraction contient au moins un membre sélectionné dans le groupe constitué d'acide folique, de vitamines B12, B6, de magnésium et de zinc.
Patent CA-2410834-C (CA)
Inventor: NIEN MING
IPC: E06B9/322
Filed: 2002-11-01
Granted: 2006-05-30
Abstract: A vertical retractable blind is constructed to include a fixed headrail, a lifting rail vertically movable in horizontal below the headrail, two positioning cords adapted to support the lifting rail at the desired elevation. The positioning cords each have a first end connected to the headrail and a second end respectively extended across the lifting rail and fixedly secured to a respective fixed point outside the lifting rail to provide a tension force to the lifting rail. A retractable blind body is connected between the headrail and the lifting rail and vertically extended out/received subject to vertical movement of the lifting rail.
Patent CA-2413051-C (CA)
Inventor: MILLER LARRY
IPC: H04N7/173
Filed: 1996-04-24
Granted: 2006-10-31
Abstract: An electronic program schedule system with product ordering capability which includes a data processor for receiving program schedule information for a plurality of programs, and a user control apparatus, such as a remote controller, for generating user control commands and transmitting signals to the data processor in response thereto. The television program schedule information is displayed on a display apparatus such as a television receiver. A video display generator receives video control commands from the data processor and program schedule information and displays a portion of the program schedule information on the receiver. The program schedule information indicates the availability of a product or service for certain of the programs included in the program information, wherein the product or service is associated with the program, such as a program transcript or videocassette. The viewer utilizes the remote control apparatus to generate a first command for displaying information on the receiver describing the product or service, and a second command for placing an order for the product or service. The data processor receives the user control commands and in response to the first command causes the video display generator to display information describing the product or service and in response to the second command generates an order for the product or service.
Patent CA-2419490-C (CA)
Inventor: HE MINGYUE
IPC: C40B50/14
Filed: 2001-08-15
Granted: 2010-01-26
Abstract: L'invention concerne un procédé de préparation d'un réseau de protéines à partir d'un ADN (ou ARNm) dans lequel un certain nombre de protéines natives et fonctionnelles, de domaines ou de peptides sont produits en parallèle par synthèse in vitro, au moyen d'un système exempt de cellule aux fins de transcription et de traduction. Les produits sont immobilisés, sous forme de grille sur une surface, au moyen d'une étiquette de séquence d'isolation incorporée dans les protéines.
Patent CA-2425342-C (CA)
Inventor: SEGUIN JACQUES
IPC: A61F2/24
Filed: 2001-10-19
Granted: 2010-12-07
Abstract: The invention concerns a support (1) comprising a structure adapted to be radially contracted to enable the insertion of the support (1)/valve (2) assembly into the patient's body, and to be unfolded to enable said structure to be supported against the wall of the site to be equipped with the cusp. The invention is characterised in that the support structure comprises: an axial portion (3) supporting the cusp (2), having a thread or thread network structure adapted to be supported against the cardiac ring (10) remaining after removal of the deficient native cusp: at least an axial wedging portion (4), having a thread or thread network structure separate from the structure of said axial portion (3) of the cusp support, and with a diameter greater than the diameter of said axial portion (3) enabling it to be supported against the wall bordering said remaining cardiac ring (10); at least a thread (5) linking point-to-point said portions (3, 4).
Patent CA-2425932-C (CA)
Inventor: HITZSCHKE LOTHAR
IPC: H01J9/24
Filed: 2002-06-26
Granted: 2010-10-19
Abstract: Procédé de fabrication d'une lampe à décharge à barrière diélectrique selon lequel, lors d'une étape de remplissage précédant la fermeture de l'espace de décharge, une partie (3) du récipient de décharge est maintenu en hauteur à l'aide d'un élément d'appui (15) qui est ensuite au moins partiellement ramolli pour abaisser la partie (3) maintenue en hauteur, ledit élément d'appui (15) étant situé à l'extérieur de l'espace de décharge.
Patent CA-2435494-C (CA)
Inventor: PITTERNA THOMAS
IPC: A01N47/48
Filed: 2002-02-26
Granted: 2011-04-19
Abstract: What is described are a compound of formula (I) in which, R1 is C1-C12alkyl, C3-C8cycloalkyl or C2-C12alkenyl; R2 is H, unsubstituted or mono- to pentasubstituted C1-C12alkyl or unsubstituted or mono-to pentasubstituted C1-C12alkenyl; R3 is C2-C12alkyl, mono- to pentasubstituted C1-C12alkyl, unsubstituted or mono- to pentasubstituted C1-C6alkoxy-C1-C6alkyl, unsubstituted or mono- to pentasubstituted C3-C12cycloalkyl, C2-C12alkenyl, C2-C12alkynal; or R2 and R3 together are an alkylene or alkenylene bridge; with the provison that R1 is not sec-butyl or isopropyl if R2 is H and R3 is 2-hydroxyethyl, isopropyl, n-octyl or benzyl; or, if appropriate, in E/Z isomer, an E/Z isomer mixture and/or a tautomer thereof; a process for preparing and using these compounds and their tautomers; pecticides whose active compound is selected from these compounds and their tautomers; and a process for preparing these compounds and compositions, and the use of these compounds and compositions.
Patent CA-2436726-C (CA)
Inventor: CHAN BENJAMIN WAI
IPC: H04B10/02
Filed: 2003-08-07
Granted: 2009-06-02
Abstract: The invention provides a method and system for selectively canceling a specified frequency band in the payload of an optical communication system. This selected frequency band is to be used for launching pilot tones for power measurement and identification. The method controls the intensity of the optical payload signal through an intensity modulator that is included in the optical communication system. The frequency band in payload to be cancelled is removed where as the other frequency components of the payload are passed without attenuation. An embodiment that uses a feed-forward unit, a feedback unit and a control unit for generating a cancellation signal for the intensity modulator is described. An advantage of the method is that it removes a continuum of payload tones in the specified frequency band to be cancelled.
Patent CA-2444295-C (CA)
Title: Sterilization system with a plasma generator controlled by a digital signal processor
Inventor: CHIEN JOHN
IPC: A61L2/18
Filed: 2003-10-07
Granted: 2010-05-11
Abstract: A sterilization system applies power to a plasma within a chamber to remove gas or vapor species from an article. The sterilization system includes a power feedback control system for controlling the power applied to the plasma. The power feedback control system includes a current monitor adapted to produce a first signal indicative of a current applied to the plasma within the chamber. The power feedback control system further includes a voltage monitor adapted to produce a second signal indicative of a voltage applied to the plasma within the chamber. The power feedback control system further includes a power control, module comprising a programmable digital signal processor. The digital signal processor is adapted to receive and process the first signal and the second signal by multiplying the current and the voltage and producing a third signal indicative of the product of the current and the voltage. The power feedback control system further includes a plasma generator coupled to the power control module and adapted to adjust, in response to the third signal, the power applied to the plasma within the chamber.
Patent CA-2444717-C (CA)
Inventor: HOFFMAN MARK A
IPC: C12Q1/68
Filed: 2002-04-18
Granted: 2017-10-31
Abstract: A method in a computer system for preventing atypical clinical events related to information identified by DNA testing a person is provided. The method includes receiving clinical agent information. The method also includes determining if a gene is associated with the clinical agent information, and if so, obtaining a genetic test result value for the associated gene of the person. The method further includes comparing the genetic test result value to a list of polymorphism values associated with an atypical clinical event, and determining whether the genetic test result value correlates to a polymorphism value on the list, and if so, outputting information about the atypical clinical event associated with the polymorphism value.
Patent CA-2447525-C (CA)
Title: Pharmaceutical and cosmetic compositions against skin aging
Inventor: DI PIERRO FRANCESCO
IPC: A61P17/00
Filed: 2002-05-10
Granted: 2010-12-14
Abstract: Pharmaceutical and cosmetic compositions for the prevention of skin aging, containing phospholipid complexes of extracts of Vitis vinifera, and phospholipid complexes of standardized extract from Centella asiatica.
Patent CA-2461951-C (CA)
Inventor: GURURAJA RAMAVANA
IPC: C12P7/62
Filed: 2001-09-27
Granted: 2011-08-09
Abstract: The present invention discloses an improved method for the manufacture of Pravastatin sodium salt by fermentation under optimal fermentation parameters using a new strain of Streptomyces flavidovirens.
Patent CA-2465039-C (CA)
Title: A handheld apparatus for semi-automatically feeding and inserting members into braille signs
Inventor: RAHAMIM REUVEN
IPC: G09F7/16
Filed: 2004-04-22
Granted: 2007-06-19
Abstract: An apparatus is disclosed for semi-automatically feeding and inserting spherically and non-spherically shaped members into pre-drilled holes on an architectural sign face corresponding to the pattern of Braille letters designed to be formed in the sign. A device is disclosed for holding a reservoir of spherically or non-spherically shaped members, delivering the members from the cylindrical storage tube to a delivery end whereby the member is forcibly inserted into the pre-drilled hole on the sign face by pressure from the user in an arrangement desired for accurately duplicating Braille letters.
Patent CA-2467303-C (CA)
Title: Outil a cintrer rotatif et methode de fabrication
Inventor: MADEJ FRANK
IPC: B21D5/02
Filed: 2004-05-14
Granted: 2008-06-17
Abstract: Un outil à cintrer rotatif possède une série de bouchons de graphite fixés dans un évidement en forme de selle en prise avec une surface de culbuteur pour en assurer la lubrification. Le culbuteur est usiné dans un état non trempé et est par la suite traité thermiquement pour être trempé, suivi du cintrage inverse du culbuteur pour corriger tout gauchissement.
Patent CA-2470148-C (CA)
Inventor: KLUXEN FRANZ-WERNER
IPC: A61P9/10
Filed: 2002-11-30
Granted: 2015-03-17
Abstract: The present invention relates to compounds suitable for the treatment of conditions which may be improved, at least in part, by increasing TNF .alpha. production. The invention further relates to assays for the identification of an individual at increased risk for or suffering from such conditions and to methods of screening compounds for their ability to enhance TNF .alpha. biosysthesis.
Patent CA-2476582-C (CA)
Title: Split inlet seal for grain separators and method
Inventor: ERNST MATTHEW J
IPC: B07B13/16
Filed: 2004-08-05
Granted: 2009-05-19
Abstract: A grain separator having an easily replaceable seal. The separator comprises a housing and a rotatable grain separation drum carried by the housing, the drum having an end face with an external annular bearing surface. A drive shaft extends axially into the drum through the end face, and a grain inlet is carried exteriorly of the housing and includes a bearing rotationally supporting an end of the drive shaft. The inlet includes an inlet spout that extends through the end face for conveying grain to the drum. An easily removable and replaceable split seal is carried about the inlet spout and engages the annular bearing surface to seal the drum from the exterior of the inlet spout, and pressure means are provided for applying axial pressure to the split seal to urge the seal against the annular bearing surface. Disclosed also is a method for seal replacement.
Patent CA-2477029-C (CA)
Inventor: ELSEGOOD CHRISTOPHER J
IPC: A61L2/10
Filed: 2004-02-04
Granted: 2008-04-08
Abstract: An ultraviolet water treatment system comprising a water chamber having a water intake for untreated water to enter the chamber, and a water outlet for water to leave the chamber; an ultraviolet light source; and a fibre optic rod having a distributing end and a receiving end, the receiving end is located to receive the focused ultraviolet light from the light source and convey the light through the rod and out the distributing end into the chamber to treat the water.
Patent CA-2478324-C (CA)
Inventor: ZIMMERLING MARTIN
IPC: A61N1/37
Filed: 2003-04-01
Granted: 2011-09-06
Abstract: L'invention concerne un aimant implantable tournant librement en réponse à un champ magnétique externe, supprimant le couple et la démagnétisation sur cet aimant, lequel peut être combiné avec une fonction de commutation électrique selon l'orientation d'un champ magnétique externe, afin de protéger une bobine et/ou de l'électronique implantées contre l'induction de surtension, ou pour assurer la commutation électrique, ou bien encore pour diverses fonctions. Le commutateur magnétique peut aussi comprendre, par exemple, un premier contact de commutation et un second contact de commutation. Un corps magnétique mou à surface conductrice peut être déplacé entre une première position de contact simultané entre le corps et les deux contacts en question, et une seconde position sans contact. Le corps et l'aimant implantable sont positionnés de sorte que le corps passe à l'une ou l'autre des positions considérées, selon le champ magnétique externe produisant une force magnétique entre l'aimant et le corps magnétique mou.
Patent CA-2484823-C (CA)
Title: Coupling device between left and right wheels of vehicle
Inventor: ARAI KENTARO
IPC: B60K17/346
Filed: 1996-08-09
Granted: 2005-11-01
Abstract: A coupling device between left and right wheels of a vehicle includes a differential gear, a driving source, a first power transmission system and a pair of second and third power transmission systems. The differential gear has a first rotational element and second and third rotational elements, one of which rotates forward, the other of which rotates in reverse. The driving source is coupled to the first rotational element. The first transmission system couples the second rotational element to the left or right wheel. The second and third power transmission systems couple the third rotational element to the other wheel. The gear ratio of the third power transmission system differs from the gear ratios of the first and second power transmission systems which are equal to each other.
Patent CA-2486495-C (CA)
Title: 9-alpha-substituted estratrienes as selectively active estrogens
Inventor: KOSEMUND DIRK
IPC: A61K31/56
Filed: 2003-06-11
Granted: 2011-04-19
Abstract: This invention describes the new 9.alpha.-substituted estratrienes of general formula (I), in which R3, R7, R7', R13, R16 as well as R17 and R17' have the meanings that are indicated in the description and R9 means a straight-chain or branched-chain, optionally partially or completely halogenated alkenyl radical with 2 to 6 carbon atoms, an ethinyl or prop-1-inyl radical, as pharmaceutical active ingredients that exhibit in vitro a higher affinity to estrogen receptor preparations from rat prostates than to estrogen receptor preparations from rat uteri and in vivo preferably a preferential action on the ovary in comparison to the uterus, their production, their therapeutic use and pharmaceutical dispensing forms that contain the new compounds. The invention also describes the use of these compounds for treating estrogen-deficiency--induced diseases and conditions.
Patent CA-2490757-C (CA)
Title: Poultry feeder
Inventor: KREGER LIONEL L
IPC: A01K39/012
Filed: 2003-06-05
Granted: 2009-01-27
Abstract: A feeder assembly for feeding birds of all kinds is provided in three separate embodiments. The feeder assembly of each embodiment is configured to provide for the welfare of birds as they feed from the feeder assembly by allowing the birds' breasts to conform to a rim member of the feeder assembly. The feeder assembly of two embodiments also provides for a lower feed gate to provide feed into a pan member of the feeder assembly. The lower feed gate is always open and can be raised or lowered as desired. The feeder assembly of one of the embodiments also provides for an upper feed gate to provide feed into the pan member of the feeder assembly. The upper feed gate can be opened or closed, and, when open, can adjust the height at which feed flows through the upper feed gate.
Patent CA-2493436-C (CA)
Inventor: ROTH GERALD JUERGEN
IPC: A61P7/02
Filed: 2003-07-22
Granted: 2011-11-08
Abstract: L'invention concerne des dérivés d'indolinone substitués en position 6, de formule générale (I), dans laquelle R¿1? à R¿6? et X ont la définition mentionnée dans la revendication (1), leurs tautomères, énantiomères, diastéréomères, leurs mélanges et leurs sels, notamment leurs sels physiologiquement acceptables, qui présentent des propriétés pharmacologiques intéressantes, notamment un effet inhibiteur sur différents récepteurs à tyrosine kinase, et sur la prolifération de cellules endothéliales et de différentes cellules tumorales. L'invention concerne également des médicaments contenant lesdits composés, l'utilisation de ces derniers et des procédés pour la préparation desdits composés.
Patent CA-2494000-C (CA)
Inventor: MCKENZIE KEVIN
IPC: B65D90/10
Filed: 2005-01-24
Granted: 2014-12-02
Abstract: A remotely activated tank hatch system includes a frame having an upper frame and a lower frame joined by a hinge assembly. The lower frame is coupled to a collar of an opening of a tank and the hatch is coupled to the upper frame. The hinge assembly allows the upper frame to pivot the hatch between an open and closed position. The frame includes at least one catch to receive an edge of the hatch, when the hatch is closed. Spring members on the upper frame urge the hatch away from the collar so that the hatch may be swung away from the opening. Inflating a rubber bladder positioned between the upper frame and hatch overcomes the spring pressure and urges the hatch into tight contact with the collar. The hatch system includes a remote control for inflating the bladder and opening and closing the hatch.
Patent CA-2496329-C (CA)
Title: Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
Inventor: FUSHIMI NOBUHIKO
IPC: A61K38/28
Filed: 2003-08-21
Granted: 2012-05-15
Abstract: The present invention provides pyrazole derivatives represented by the general formula: (see formula I) wherein R1 represents H, an optionally substituted C1-6 alkyl group etc.; one of Q and T represents a group represented by the general formula: (see formula II) or a group represented by the general formula: (see formula III) while the other represents an optionally substituted C1-6 alkyl group etc.; R2 represents H, a halogen atom, OH, an optionally substituted C1-6 alkyl group etc.; X represents a single bond, O or S; Y represents an optionally substituted C1-6 alkylene group etc.; Z represents -R B, COR C etc. in which R B represents an optionally substituted C1-6 alkyl group etc.; and R C represents an optionally substituted C1-6 alkyl group etc.,; R4 represents H, an optionally substituted C1-6 alkyl group etc.; and R3, R5 and R6 represent H, a halogen atom etc., pharmaceutically acceptable salts thereof or prodrugs thereof, which exhibit an excellent inhibitory activity in human SGLT1 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity, and a disease associated with the increase of blood galactose level such as galactosemia, and pharmaceutical compositions comprising the same, pharmaceutical uses thereof, and intermediates for production thereof.
Patent CA-2496413-C (CA)
Title: Filter for the depletion of leukocytes from blood products
Inventor: MARI GIORGIO
IPC: A61M1/02
Filed: 2003-08-19
Granted: 2011-04-19
Abstract: A filter device for the depletion of the leukocyte content from blood products including two or more porous elements each made of one or more layers or filtering materials, wherein said porous elements are arranged in the filter device according to decreasing hydrophilicity, from inlet to outlet, of the filtering material constituting said elements.